Medicaid Expansion and Breast Cancer Screening in Appalachia and Non-Appalachia, United States, BRFSS 2003 to 2015.
Aged
Appalachian Region
Behavioral Risk Factor Surveillance System
Breast Neoplasms
/ diagnosis
Early Detection of Cancer
/ statistics & numerical data
Female
Humans
Mammography
/ statistics & numerical data
Medicaid
/ statistics & numerical data
Medically Underserved Area
Middle Aged
Patient Protection and Affordable Care Act
/ statistics & numerical data
Risk Factors
Social Class
United States
Medicaid expansion
breast cancer screening
mammography
Journal
Cancer control : journal of the Moffitt Cancer Center
ISSN: 1526-2359
Titre abrégé: Cancer Control
Pays: United States
ID NLM: 9438457
Informations de publication
Date de publication:
Historique:
entrez:
10
5
2019
pubmed:
10
5
2019
medline:
21
11
2019
Statut:
ppublish
Résumé
Prior data suggests that breast cancer screening rates are lower among women in the Appalachian region of the United States. This study examined the changes in breast cancer screening before and after the implementation of the Affordable Care Act Medicaid expansion, in Appalachia and non-Appalachia states. Data from the Behavioral Risk Factor Surveillance System between 2003 and 2015 were analyzed to evaluate changes in breast cancer screening in the past 2 years among US women aged 50-74 years. Multivariable adjusted logistic regression and generalized estimating equation models were utilized, adjusting for sociodemographic, socioeconomic, and health-care characteristics. Data were analyzed for 2 periods: 2003 to 2009 (pre-expansion) and 2011 to 2015 (post-expansion) comparing Appalachia and non-Appalachia states. The prevalence for of self-reported breast cancer screening in Appalachia and non-Appalachia states were 83% and 82% ( P < .001), respectively. In Appalachian states, breast cancer screening was marginally higher in non-expanded versus expanded states in both the pre-expansion (relative risk [RR]: 1.002, 95% confidence interval [CI]: 1.002-1.003) and post-expansion period (RR: 1.001, 95% CI: 1.001-1.002). In non-Appalachian states, screening was lower in non-expanded states versus expanded states in both the pre-expansion (RR: 0.98, 95% CI: 0.97-0.98) and post-expansion period (RR: 0.95, 95% CI: 0.95-0.96). There were modest 3% to 4% declines in breast cancer screening rates in the pos-texpansion period regardless of expansion and Appalachia status. Breast cancer screening rates were higher in Appalachia versus non-Appalachia US states and higher in expanded versus nonexpanded non-Appalachia states. There were modest declines in breast cancer screening rates in the post-expansion period regardless of expansion and Appalachia status, suggesting that more work may be needed to reduce administrative, logistical, and structural barriers to breast cancer screening services.
Sections du résumé
BACKGROUND
BACKGROUND
Prior data suggests that breast cancer screening rates are lower among women in the Appalachian region of the United States. This study examined the changes in breast cancer screening before and after the implementation of the Affordable Care Act Medicaid expansion, in Appalachia and non-Appalachia states.
METHODS
METHODS
Data from the Behavioral Risk Factor Surveillance System between 2003 and 2015 were analyzed to evaluate changes in breast cancer screening in the past 2 years among US women aged 50-74 years. Multivariable adjusted logistic regression and generalized estimating equation models were utilized, adjusting for sociodemographic, socioeconomic, and health-care characteristics. Data were analyzed for 2 periods: 2003 to 2009 (pre-expansion) and 2011 to 2015 (post-expansion) comparing Appalachia and non-Appalachia states.
RESULTS
RESULTS
The prevalence for of self-reported breast cancer screening in Appalachia and non-Appalachia states were 83% and 82% ( P < .001), respectively. In Appalachian states, breast cancer screening was marginally higher in non-expanded versus expanded states in both the pre-expansion (relative risk [RR]: 1.002, 95% confidence interval [CI]: 1.002-1.003) and post-expansion period (RR: 1.001, 95% CI: 1.001-1.002). In non-Appalachian states, screening was lower in non-expanded states versus expanded states in both the pre-expansion (RR: 0.98, 95% CI: 0.97-0.98) and post-expansion period (RR: 0.95, 95% CI: 0.95-0.96). There were modest 3% to 4% declines in breast cancer screening rates in the pos-texpansion period regardless of expansion and Appalachia status.
CONCLUSIONS
CONCLUSIONS
Breast cancer screening rates were higher in Appalachia versus non-Appalachia US states and higher in expanded versus nonexpanded non-Appalachia states. There were modest declines in breast cancer screening rates in the post-expansion period regardless of expansion and Appalachia status, suggesting that more work may be needed to reduce administrative, logistical, and structural barriers to breast cancer screening services.
Identifiants
pubmed: 31067985
doi: 10.1177/1073274819845874
pmc: PMC6509986
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1073274819845874Références
Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):137-42
pubmed: 11815412
Am J Public Health. 2003 May;93(5):786-91
pubmed: 12721145
Ethn Dis. 2003 Fall;13(4):477-84
pubmed: 14632267
Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1182-7
pubmed: 14652278
J Rural Health. 2004 Spring;20(2):181-7
pubmed: 15085633
J Rural Health. 2005 Winter;21(1):39-47
pubmed: 15667008
Prev Chronic Dis. 2006 Oct;3(4):A113
pubmed: 16978488
Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):748-57
pubmed: 18381468
Annu Rev Public Health. 2009;30:43-54
pubmed: 19705555
J Rural Health. 2009 Fall;25(4):366-71
pubmed: 19780916
Ann Intern Med. 2009 Nov 17;151(10):716-26, W-236
pubmed: 19920272
Ann Intern Med. 2009 Nov 17;151(10):727-37, W237-42
pubmed: 19920273
Health Serv Res. 2011 Feb;46(1 Pt 1):173-84
pubmed: 21029084
Radiology. 2011 Sep;260(3):658-63
pubmed: 21712474
Popul Health Metr. 2011 Sep 30;9:54
pubmed: 21961697
Cancer Causes Control. 2012 Jan;23(1):165-73
pubmed: 22080276
JAMA. 2012 Jan 25;307(4):369-70
pubmed: 22274682
Int J Equity Health. 2012 Mar 21;11:16
pubmed: 22436125
MMWR Morb Mortal Wkly Rep. 2012 Jun 8;61(22):410-3
pubmed: 22672976
Cochrane Database Syst Rev. 2013 Jun 04;(6):CD001877
pubmed: 23737396
Women Health. 2013;53(6):552-71
pubmed: 23937729
Health Serv Res. 2014 Apr;49(2):546-67
pubmed: 24117371
Am J Prev Med. 2014 Apr;46(4):359-67
pubmed: 24650838
Medicare Medicaid Res Rev. 2013 Nov 22;3(4):null
pubmed: 24834369
J Oncol Pract. 2015 Jan;11(1):e9-e18
pubmed: 25228530
Am J Prev Med. 2015 Jan;48(1):98-103
pubmed: 25441234
Health Commun. 2016;31(1):72-82
pubmed: 25668682
Cancer Causes Control. 2015 May;26(5):671-86
pubmed: 25783455
Prev Med. 2015 Sep;78:85-91
pubmed: 26209914
Prog Community Health Partnersh. 2015;9 Suppl:21-32
pubmed: 26213401
JAMA. 2015 Jul 28;314(4):366-74
pubmed: 26219054
Am J Public Health. 2015 Nov;105 Suppl 5:S706-12
pubmed: 26447909
Med Care. 2015 Nov;53(11):980-8
pubmed: 26465126
Am J Prev Med. 2016 Feb;50(2):161-70
pubmed: 26497264
Prev Chronic Dis. 2015 Dec 31;12:E231
pubmed: 26719901
J Prim Care Community Health. 2016 Jul;7(3):149-58
pubmed: 26906524
Inquiry. 2016 Apr 13;53:null
pubmed: 27076474
JAMA. 2016 Aug 2;316(5):525-32
pubmed: 27400401
Cancer. 2017 May 1;123(9):1585-1589
pubmed: 28067955
MMWR Surveill Summ. 2017 Feb 24;66(7):1-42
pubmed: 28231239
Cancer J. 2017 May/Jun;23(3):151-162
pubmed: 28537960
Prev Med Rep. 2017 Apr 05;7:239-245
pubmed: 28879070
CA Cancer J Clin. 2017 Nov;67(6):439-448
pubmed: 28972651
Am J Public Health. 1996 Jul;86(7):1016-21
pubmed: 8669504